RecruitingNot Applicable

Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients

China150 participantsStarted 2026-01-01

Plain-language summary

The goal of this clinical trial is to evaluate the usefulness and effectiveness of a newly developed artificial intelligence (AI) chatbot for health education in thyroid cancer patients during the period around their surgery (the perioperative period). The main questions it aims to answer are: Does the AI chatbot improve patients' readiness for discharge, quality of recovery, and active engagement in their own healthcare compared to traditional education methods? How do patients rate the usability and friendliness of this new AI chatbot system? Researchers will compare a group of patients who receive traditional health education (the control group) with a subsequent group of patients who use the new AI chatbot built on the "Coze" platform (the intervention group) to see if the AI chatbot leads to better recovery experiences and higher patient engagement. Participants will be asked to: Access and interact with the AI chatbot to receive personalized health guidance, ask questions, and get instant feedback during their hospital stay. Complete a set of questionnaires on the morning of their hospital discharge to evaluate their recovery quality, readiness to leave the hospital, and level of engagement in their care. Complete an extra survey regarding the usability and acceptability of the chatbot system (only for participants in the AI chatbot group).

Who can participate

Age range

18 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with thyroid cancer in accordance with the clinical diagnostic criteria, and confirmed by ultrasonography and histopathological examination. * Scheduled to undergo elective surgery for thyroid cancer. * Mentally competent to understand the study protocol, and voluntarily provided written informed consent to participate in this study. Exclusion Criteria: * Aged less than 18 years. * Concurrently diagnosed with malignant tumors in other organs or severe complications/dysfunctions of other major organs. * Patients who are anticipated to be unable to complete the study protocol due to plans for hospital/department transfer, or high risk of treatment discontinuation.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Readiness for Hospital Discharge

Timeframe: On the morning of hospital discharge

Postoperative Quality of Recovery

Timeframe: On the morning of hospital discharge

System Usability of the AI Chatbot

Timeframe: On the morning of hospital discharge.

Trial details

NCT IDNCT07634978

SponsorTianjin Medical University Cancer Institute and Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08-01

Contact for this trial

jiayan Cao

86+23340123-3130 Caojiayan_1976@126.com

View on ClinicalTrials.gov More Thyroid Cancer trials